Junichi Nakashima

Learn More
AIM Haemodynamically significant patent ductus arteriosus (hsPDA) is frequently observed in premature infants. This study was conducted to explore whether the blood BNP can be a valuable biomarker to assess the necessity of treatment for hsPDA in premature infants. METHODS Serial measurements of the blood BNP were performed during the first 5 days of life(More)
  • 1